Literature DB >> 31580388

Broad Application of Multigene Panel Testing for Breast Cancer Susceptibility-Pandora's Box Is Opening Wider.

Mark Robson1, Susan Domchek2.   

Abstract

Entities:  

Year:  2019        PMID: 31580388     DOI: 10.1001/jamaoncol.2019.4004

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.

Authors:  Siddhartha Yadav; Chunling Hu; Steven N Hart; Nicholas Boddicker; Eric C Polley; Jie Na; Rohan Gnanaolivu; Kun Y Lee; Tricia Lindstrom; Sebastian Armasu; Patrick Fitz-Gibbon; Karthik Ghosh; Daniela L Stan; Sandhya Pruthi; Lonzetta Neal; Nicole Sandhu; Deborah J Rhodes; Christine Klassen; Prema P Peethambaram; Tufia C Haddad; Janet E Olson; Tanya L Hoskin; Matthew P Goetz; Susan M Domchek; Judy C Boughey; Kathryn J Ruddy; Fergus J Couch
Journal:  J Clin Oncol       Date:  2020-03-03       Impact factor: 44.544

2.  Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019.

Authors:  Allison W Kurian; Kevin C Ward; Paul Abrahamse; Irina Bondarenko; Ann S Hamilton; Dennis Deapen; Monica Morrow; Jonathan S Berek; Timothy P Hofer; Steven J Katz
Journal:  J Clin Oncol       Date:  2021-02-09       Impact factor: 44.544

3.  Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.

Authors:  Julie O Culver; Charité N Ricker; Joseph Bonner; John Kidd; Duveen Sturgeon; Rachel Hodan; Kerry Kingham; Katrina Lowstuter; Nicolette M Chun; Alexandra P Lebensohn; Courtney Rowe-Teeter; Peter Levonian; Katlyn Partynski; Karlena Lara-Otero; Christine Hong; Jennifer Morales Pichardo; Meredith A Mills; Krystal Brown; Caryn Lerman; Uri Ladabaum; Kevin J McDonnell; James M Ford; Stephen B Gruber; Allison W Kurian; Gregory E Idos
Journal:  Cancer       Date:  2020-12-15       Impact factor: 6.921

4.  Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants.

Authors:  Nicholas J Roberts; Robert C Grant; Steven Gallinger; Alison P Klein
Journal:  Genes Chromosomes Cancer       Date:  2021-04-01       Impact factor: 5.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.